Biogen Inc.

Location

Massachusetts

Founded

1978-02-28

Risk Signals

6616 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Recent Articles about Biogen Inc.

Live alerts from global media, monitored by Business Radar

Biogen Plans For State-of-the-Art Global Headquarters At Kendall Common, Set To Open In 2028 |

2025-03-24 (nasdaq.com)

Biogen Plans For State-of-the-Art Global Headquarters At Kendall Common, Set To Open In 2028 |

(RTTNews) - Biogen Inc. (BIIB) announced Monday plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real estate consolidation plan in Massachusetts.

Read more
Biogen in talks to move to MIT's Volpe development, sources say

2024-12-20 (bizjournals.com)

Biogen in talks to move to MIT's Volpe development, sources say

The move would carry major ramifications for Kendall Square and a sluggish life sciences real estate market.

Read more

Never miss a headline about Biogen Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages